Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA
|
| Posted
:
Thu, 29 Oct 2009 12:09:51 GMT |
| Author
:
Novavax, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
ROCKVILLE, Md., Oct.29 MD-Novavax-poster
ROCKVILLE, Md., Oct.29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that its abstract has been selected for poster presentation at the Infectious Diseases Society of America (IDSA) 47th Annual meeting being held in Philadelphia, Pennsylvania from October 29 - November 1, 2009.
Poster presentation: "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Healthy Adults", Penny Heaton, M.D., Maria Allende, M.D., Kathy Lenhard, R.N., Mike Massare, PhD., and Mark Wolff, PhD. Saturday October 31, 2009 12:30 pm to 2:00 pm., Pennsylvania Convention Center, Poster Hall A.
About the 47th Annual Meeting of the IDSA
This conference will showcase abstract presentations containing outstanding, noteworthy science; and expanded roster of challenging interactive sessions; symposia on management of difficult pathogens, such as MRSA, Clostridium difficle, and drug-resistant mycobacteria, gram-negative bacillia and fungi; and the promises and challenges of new vaccines. The Special Plenary Session and Named Lectures will highlight important advancements as well as challenges in the world of infectious diseases. Additional information is available at www.idsociety.org.
About Novavax
Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com
SOURCE Novavax, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
First Gold Hires Investor Relations Firm
LAVAL, QUEBEC -- 11/26/09 --
First Gold Exploration Inc. (TSX VENTURE: EFG)(FRANKFURT: F12) is pleased to announce that it has engaged the services of National Media Associates, an independent firm of investor relations. National Media Associates w..
Media Release-KAIROS Partners Murdered in Philippines: A Response to the Massacre
TORONTO, ONTARIO -- 11/26/09 --
Attention: Religion, Foreign, and Human Rights Journalists
KAIROS: Canadian Ecumenical Justice Initiatives condemns the murder of 57 people in the Philippines, including two of its human rights partners, an..
Brompton Funds Announces Investor Conference Calls with Portfolio Manager: MFC Global Investment Management
TORONTO, ONTARIO -- 11/26/09 --
Brompton Funds (TSX: AOG.UN)(TSX: AOG.WT.A) (TSX: AV.UN)(TSX: AV.WT.A) (TSX: MBB.UN)(TSX: OGF.UN)(TSX: OGF.WT.A)(TSX: VIP.UN)(TSX: VIP.WT.A) is pleased to announce that it will be hosting three investor conference ca..
Ventana Provides Corporate Development Update and Announces Dispute Respecting La Bodega Agreement
VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
Ventana Gold Corp. (TSX: VEN) ("Ventana" or "the Company") has been advised that Sociedad Minera La Bodega Limitada (or the "Vendor"), the owner of the mineral rights to the La Bodega property in Colombia,..
BioSyent Releases 2009 Third Quarter Financial Results
MISSISSAUGA, ONTARIO -- 11/26/09 --
BioSyent Inc. ("BioSyent")(TSX VENTURE: RX) today released a summary of its 2009 third quarter financial results.
During the third quarter ended September 30, 2009 sales increased by 17%, from $431,841 ..
Pacific Safety Products Inc. Announces Fiscal Year 2010 First Quarter Results
KANATA, ONTARIO -- 11/26/09 --
Pacific Safety Products Inc. (TSX VENTURE: PSP) ("PSP" or "the Company") today announced consolidated financial results for the three month period ended September 30, 2009.
Recent Developments:
- R..
Explorator Reports Third Quarter 2009 Results
TORONTO, ONTARIO -- 11/26/09 --
Explorator Resources Inc. ("Explorator" or the "Company")(TSX VENTURE: EXO) reports its financial results for the three and nine month period ended September 30, 2009. Set out herein are the highlights and an excerpt..
|
|
|
|
|
|
|
|
|
